Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Titel:
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Auteur:
Hotchkiss, Richard S. Colston, Elizabeth Yende, Sachin Crouser, Elliott D. Martin, Greg S. Albertson, Timothy Bartz, Raquel R. Brakenridge, Scott C. Delano, Matthew J. Park, Pauline K. Donnino, Michael W. Tidswell, Mark Mayr, Florian B. Angus, Derek C. Coopersmith, Craig M. Moldawer, Lyle L. Catlett, Ian M. Girgis, Ihab G. Ye, June Grasela, Dennis M.